Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association

Diabetes Care. 2009 Jan;32(1):187-92. doi: 10.2337/dc08-9026. Epub 2008 Dec 17.

Authors

Jay S Skyler¹, Richard Bergenstal, Robert O Bonow, John Buse, Prakash Deedwania, Edwin A M Gale, Barbara V Howard, M Sue Kirkman, Mikhail Kosiborod, Peter Reaven, Robert S Sherwin; American Diabetes Association; American College of Cardiology Foundation; American Heart Association

Affiliation

¹ University of Miami, Miami, Florida, USA.

No abstract available

Publication types

Practice Guideline

MeSH terms

Adult
Aged
Blood Glucose / analysis*
Cardiovascular Diseases / prevention & control*
Diabetes Complications / prevention & control*
Diabetes Mellitus, Type 1 / blood
Diabetes Mellitus, Type 1 / diagnosis
Diabetes Mellitus, Type 1 / drug therapy
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / diagnosis
Diabetes Mellitus, Type 2 / drug therapy
Diabetic Angiopathies / prevention & control
Homeostasis
Humans
Hyperglycemia / prevention & control*
Middle Aged
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Sensitivity and Specificity

Substances

Blood Glucose